Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 3 days ago

X4 Pharmaceuticals, Inc: Deep Track Capital, LP amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Deep Track Capital, LP amended its Schedule 13G filing for X4 Pharmaceuticals, Inc., according to SEC accession 0001172661-26-005081. The filing updates the institutional investor's reported stake in the clinical-stage biopharmaceutical company. The amendment signals a change in Deep Track's position, though the filing summary did not disclose the revised share count or percentage. Investors will watch for the full filing details to gauge whether the adjustment reflects accumulation or reduction.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

X4 Pharmaceuticals, Inc., Deep Track Capital, LP